Cargando…
Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Schizophrenia (SCZ) is a complex psychiatric disorder of multifactorial origin, in which both genetic and environmental factors have an impact on its onset, course, and outcome. Large variability in response and tolerability of medication among individuals makes it difficult to predict the efficacy...
Autores principales: | Płaza, Olga, Gałecki, Piotr, Orzechowska, Agata, Gałecka, Małgorzata, Sobolewska-Nowak, Justyna, Szulc, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775397/ https://www.ncbi.nlm.nih.gov/pubmed/36551925 http://dx.doi.org/10.3390/biomedicines10123165 |
Ejemplares similares
-
Exploring the Heart–Mind Connection: Unraveling the Shared Pathways between Depression and Cardiovascular Diseases
por: Sobolewska-Nowak, Justyna, et al.
Publicado: (2023) -
Ways of Coping with Stress among Patients with Depressive Disorders
por: Orzechowska, Agata, et al.
Publicado: (2022) -
Expression of p11 in Patients with Depression
por: Gałecka, Małgorzata, et al.
Publicado: (2022) -
Emotional control in selected somatic and psychiatric diseases
por: Orzechowska, Agata, et al.
Publicado: (2023) -
Inflammatory versus Anti-Inflammatory Profiles in Major Depressive Disorders—The Role of IL-17, IL-21, IL-23, IL-35 and Foxp3
por: Gałecka, Małgorzata, et al.
Publicado: (2021)